Clinical Trials Directory

Trials / Unknown

UnknownNCT04475263

Cognitive and Blood Biomarker Assessment After CO Exposure

Cognitive, Behavioural and Blood Biomarker Assessment After Carbon Monoxide (CO) Exposure

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
St George's, University of London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Carbon monoxide (CO) is reported to cause around 30 deaths, 200 admissions and 4000 presentations to Emergency Departments each year in the UK. In the longer term, CO poisoning is recognised to cause persistent neurological problems (including impairments of thinking and behavioural changes), which can develop days to weeks after the initial exposure. However, the incidence of these long-term sequelae is unknown. In addition, there is evidence of long-lasting inflammatory changes in the brain and on-going brain cell injury, although how long this persists is also unknown. Initial assessments of CO exposure can be unreliable if blood tests are not carried out within a relatively short period after the exposure and other biomarkers (such as imaging) are insensitive to detecting previous CO exposure. Certain proteins that are found in brain cells can be detected in the blood of individuals following brain injury and brain cell death. These proteins have been found to be raised in the acute period after minor head injury, persistently raised in patients with a traumatic brain injury and evidence of on going neurodegeneration (i.e. on going brain cell death) and in patients with various types of dementia. The investigators will assess the presence of these proteins in the blood of 50 participants with proven CO exposure in the sub-acute to chronic timescale (2 weeks to 2 years). This has not been done before and will allow assessment of the presence of on going brain injury in these participants. The investigators will also assess cognitive (e.g. memory, attention and speed of thinking) and behavioural impairments in these participants to help characterise the common impairments suffered following CO exposure and relate these to evidence of persistent brain injury and severity of CO exposure.

Conditions

Timeline

Start date
2020-11-01
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2020-07-17
Last updated
2020-10-22

Source: ClinicalTrials.gov record NCT04475263. Inclusion in this directory is not an endorsement.